Follow Evaxion Biotech A/S. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.
5 Stories in coverage 0 Programs 1 Registered trial 424B3 Nov 13 Latest SEC filing Nov 12 Latest story
Timeline 5 Pipeline 0 Trials 1
All5 Regulatory1 Trials and readouts4 Filings and people2
Details
Headquarters Hoersholm Incorporated Denmark Industry Biological Products, (No Diagnostic Substances) Formerly Evaxion Biotech A/S (to 2025) Also known as EVAX, Evaxion A/S How the company describes itself Evaxion Biotech develops personalized and off-the-shelf cancer vaccines and prophylactic vaccines for infectious diseases using its AI-Immunology platform. The company, based in Denmark, has clinical-stage candidates in its pipeline. source